SPY425.10+2.50 0.59%
DIA341.98+3.20 0.94%
IXIC14,369.71+97.98 0.69%

REFILE-BRIEF-Hubei Biocause Pharmaceutical Posts Life Insurance Unit's Premium Income

05/11/2021 05:17
REFILE-BRIEF-Hubei Biocause Pharmaceutical Posts Life Insurance Unit's Premium Income

Refiles to add source text link

- Hubei Biocause Pharmaceutical Co Ltd 000627.SZ:

  • SAYS LIFE INSURANCE UNIT'S PREMIUM INCOME TOTALLED 12.7 BILLION YUAN ($1.98 billion) IN JANUARY-APRIL

Source text in Chinese: https://bit.ly/3tE09ea

Further company coverage: 000627.SZ


($1 = 6.4224 Chinese yuan renminbi)


(Reporting by Hong Kong newsroom)

(([email protected]; 852-39525805;))